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Background The role of a tailored surgical approach for hypertrophic cardiomyopathy (HCM) on
regional ventricular remodelling remains unknown. The aims of this study were to evaluate the
pattern, extent and functional impact of regional ventricular remodelling after a tailored surgical
approach.
Methods From 2005 to 2008, 44 patients with obstructive HCM underwent tailored surgical
intervention. Of those, 14 were ineligible for cardiac magnetic resonance (CMR) studies. From the
remainder, 14 unselected patients (42± 12 years) underwent pre- and post-operative CMR studies at
a median 12 months post-operatively (range 4–37 months). Regional changes in left ventricular (LV)
thickness as well as global LV function following surgery were assessed using CMR Tools (London, UK).
Results Pre-operative mean echocardiographic septal thickness was 21± 4mm and mean LV
outflow gradient was 69± 32mmHg. Following surgery, there was a significant degree of regional
regression of LV thickness in all segments of the LV, ranging from 16% in the antero-lateral
midventricular segment to 41% in the anterior basal segment. Wall thickening was significantly
increased in basal segments but showed no significant change in the midventricular or apical
segments. Globally, mean indexed LV mass decreased significantly after surgery (120± 29 g/m2
versus 154± 36 g/m2; p < 0.001). There was a trend for increased indexed LV end-diastolic volume
(70± 13mL versus 65± 11mL; p = 0.16) with a normalization of LV ejection fraction (68± 7% versus
75± 9%; p < 0.01).
Conclusion Following a tailored surgical relief of outflow obstruction for HCM, there is a marked
regional reverse LV remodelling. These changes could have a significant impact on overall ventricular
dynamics and function.
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INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disease which can present with a
wide spectrum of phenotypic manifestations affecting the interventricular septum, the ventricular
muscle, the mitral valve, the subvalvular apparatus and the papillary muscles [1–4]. These
abnormalities can result in dysfunction of the left ventricular outflow tract (LVOT) resulting in dynamic
LVOT obstruction [5], which is identified in up to 70% of subjects with HCM [6]. In addition to causing
symptoms, LVOT obstruction is a direct prognostic indicator of long-term patient survival [7]. Thus,
relief of LVOT obstruction has important clinical implications on both morbidity and mortality.
Along with the septal location, ventricular hypertrophy affecting areas of the left ventricle (LV)
remote from the septum has been well recognized [3,4,8,9]. Hypertrophy of remote areas can be part
of the disease process or represent a compensatory mechanism secondary to increased afterload due
to LVOT obstruction, a matter yet unresolved [1]. The degree of LV hypertrophy estimated by indexed
LV mass or thickness is an important predictor of outcomes in patients with HCM [4,10]. Thus,
although the primary objective of surgery in HCM is the relief of LVOT obstruction, its effect on the
different segments of the LV may also be significant. The pattern of LV remodelling following alcohol
septal ablation (ASA) has been previously evaluated [11]. However, the specific aspect of regional LV
response in structure and function following surgical myectomy has not been studied before.
Several surgical and interventional techniques have been described for patients with
HCM [12–17]. We have evolved a tailored surgical approach for the treatment of LVOT dysfunction
which targets the various components of the disease including the septum, the fibrous trigones, the
papillary muscles and subvalvular apparatus (see Methods). This technique aims to correct both the
structure and function of the LVOT by restoring its normal dynamics, particularly at the level of the
aortic-mitral junction [5].
Using cardiac magnetic resonance (CMR), the objectives of this study were to analyze the pattern
and degree of regional and global LV remodelling following tailored surgical treatment of LVOT
dysfunction. We specifically examined regional changes in LV thickness and thickening following
surgery as well as global changes in LV volumes, systolic function and mass.
METHODS
Patient population
From 2005 to 2008, 44 patients with obstructive HCM refractory to maximal medical therapy
underwent tailored LVOT reconstructive procedure at the Azienda Ospedaliera Universitaria Careggi
(Florence, Italy). All patients were invited to undergo pre- and post-operative CMR studies except for
14 patients who could not undergo CMR examination because of an implantable
cardioverter-defibrillator (n = 8) or claustrophobia (n = 6). Of the remainder, 14 patients underwent
complete pre- and post-operative CMR examinations (n = 28 studies) and were included for this
study. Comparison of included and non-included patients showed no differences between the two
groups in terms of pre-, per- and post-operative outcomes (data not shown).
Patient characteristics and operative data of the study cohort (n = 14) are presented in Table 1.
Mean age of the patients was 42± 12 years (n = 10male; 71%). Mean maximum LVOT gradient
measured by echocardiography was 68± 27mmHg. All patients were on beta-blocker therapy pre-
and post-operatively. Two patients (14%) had treated hypertension. There were no other significant
comorbidities.
Surgical technique
Our surgical technique targets all components of LVOT dysfunction in a tailored fashion. Briefly,
through a trans-aortic approach, an extended septal myectomy (Fig. 1) guided by pre-operative
imaging of the depth, width and length of muscle hypertrophy, is performed. The left and right fibrous
trigones are then explored and mobilized by removing the fibrous tissue from the angles of the
trigones, thus restoring the normal mobility of the subaortic curtain [5]. To correct anterior
displacement of the papillary muscles or their attachment to the lateral LV wall, the papillary muscles
are thinned or mobilized from the free wall of the LV and abnormal chords restricting their mobility
are cut. In addition, any obstructive accessory chord or mitral valve tissue is removed. Importantly,
the mitral valve apparatus is preserved in all patients with no enlargement [12] or plication [13] of
the anterior leaflet. On post-operative day 5, beta-blocker therapy is systematically reintroduced for
all patients.
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Table 1. Patient characteristics and operative outcomes.
Variable Pre-op
Age (yrs) 42± 12
Male gender; n (%) 10 (71)
BSA (m2) 1.9± 0.2
Time from surgery (median) 12 (4–37)
Clinical presentation




Max LVOT Gradient (mmHg) 68± 27
Septum (mm) 25± 4
Posterior wall (mm) 11± 2
30-Day Mortality 0 (0)
Post-operative gradient (mmHg) 9± 6
Figure 1. Myectomy specimen illustrating the extent of the resected muscle which includes the area of
subendocardial fibrosis on the septum and three muscle bands extending into the midventricular region.
CMR studies
CMR was performed pre-operatively and at a minimum period of 4 months following operation
(median 12 months; range 4–37 months). Magnetic resonance imaging was performed using a 1.5 T
scanner (Intera 1.5 T Philips, gradient slope 30 mT/m) with a 5 element phased array coil. Cine
images were acquired in multiple short-axis and long-axis views with a breath-hold, retrospective
steady-state free precession sequence (slice thickness 8 mm, echo time 1.53 ms, matrix 168× 195,
SENSE factor 1.8). The number of k-space lines for each heartbeat was adjusted to permit the
acquisition of 30 cardiac phases covering the whole cardiac cycle. The field of view was 340 mm on
average and adapted to the size of the patient, leading to a spatial resolution of about 2 mm. A
gadolinium-based contrast agent (0.1 mMol/kg) was then given intravenously, and
contrast-enhanced images were acquired by using a 3D breath-hold inversion-recovery segmented
gradient-echo sequence in the same views used for cine cardiac magnetic resonance series,
10–15 min after contrast administration. The optimal inversion time (IT) was obtained for each
patient by visual inspection of a preliminary acquisition of a single-slice multi-IT series. The optimal IT
(usually between 175 and 260 ms) was the one providing the best contrast between the myocardium
and the left ventricular chamber.
Image analysis
Image analysis was performed using CMR Tools (CMR Tools Inc., London, UK), a validated and
clinically approved image analysis software specifically designed for in-depth analysis of CMR
studies. Importantly, it allows regional assessment of the LV by dividing it into 17 segments as
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17.  apex
1.  basal anterior
2.  basal anteroseptal
3.  basal inferoseptal
4.  basal inferior
5.  basal inferolateral
6.  basal anterolateral
7. mid anterior
8.  mid anteroseptal
9.  mid inferoseptal
10.  mid inferior
11.  mid inferolateral
12.  mid anterolateral
13.  apical anterior
14  apical septal
15.  apical inferior
















Figure 2. Schematic representation of the 17 left ventricular segments as recommended by the American Heart
Association Standardized Myocardial Segmentation and Nomenclature for Imaging Guidelines.
recommended by the American Heart Association Standardized Myocardial Segmentation and
Nomenclature for Imaging Guidelines (Fig. 2) [18].
Regional analyses
Regional analyses focused on segmental changes in LV thickness and thickening following surgery.
The analysis was performed by manually delineating the endocardial and epicardial borders of the LV
on each successive short-axis cine image. For LV thickness, measurements were made at
end-diastole. Thickening was measured as the increase in ventricular thickness from end-diastole to
end-systole. Papillary muscles were manually excluded from the analysis of LV on all short-axis views.
Global analyses
Global LV analysis consisted of changes in LV end-systolic and end-diastolic volumes (LVESV and
LVEDV), LV ejection fraction (LVEF) and indexed LV mass. Using the same manual delineation method,
LV volumes and ejection fraction were estimated. In addition, myocardial mass was calculated from
contiguous short-axis views employing Simpson’s rule. When multiplied by the density of myocardial
tissue (1.05 g/cm3), the LV mass was obtained and indexed to body surface area (BSA) [19]. Left
ventricular remodelling index (LVRI) defined as the LV mass/volume ratio was also assessed. LVRI has
been reported to affect diastolic function parameters independent of intrinsic diastolic function and
filling pressures [20]. In addition, pre- and post-operative LV longitudinal function was evaluated by
measuring the mitral annular plane systolic excursion (MAPSE) during the cardiac cycle using CMR
images in 2- and 4-chamber views.
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Table 2. Changes in regional LV end-diastolic thickness following tailored surgical myectomy for
HCM
LV Segment Pre-operative (mm) Post-operative (mm) % Change p-value
Basal
Anterior 12.4± 2.9 7.3± 2.4 −41% < 0.001
Antero-Septal 11.9± 3.7 7.6± 3.5 −36% 0.03
Infero-Septal 13.3± 4.4 8.1± 2.8 −39% < 0.001
Inferior 12.1± 2.6 8.4± 3.1 −31% < 0.001
Infero-Lateral 12.3± 2.4 8.1± 2.6 −34% < 0.001
Antero-Lateral 13.8± 3.6 9.8± 2.3 −29% 0.01
Mid
Anterior 17.2± 5.3 13.1± 4.2 −24% 0.03
Antero-Septal 17.2± 5.9 13.9± 4.5 −19% 0.02
Infero-Septal 16.3± 5.2 13.1± 4.1 −20% 0.02
Inferior 14.5± 3.0 11.7± 2.6 −19% < 0.01
Infero-Lateral 13.5± 3.0 10.7± 2.5 −21% < 0.01
Antero-Lateral 15.0± 2.7 12.6± 3.4 −16% 0.03
Apical Anterior 13.6± 5.1 10.9± 5.1 −20% 0.23
Septal 14.6± 5.0 10.3± 4.4 −29% 0.02
Inferior 12.7± 3.2 9.0± 2.3 −29% < 0.001
Lateral 12.5± 3.2 9.3± 2.9 −26% < 0.001
Apex Apex 8.7± 2.8 6.2± 1.1 −29% 0.02
Statistical methods
Data are expressed as mean± standard deviation or median (range) for continuous variables and as
number (percentage) for categorical variables. Univariable analyses included two-tailed Wilcoxon
rank sum or Student’s t-test for continuous variables and Fisher’s exact test for discrete variables. A
p-value<0.05 was considered statistically significant.
RESULTS
Operative results
Patient characteristics and operative outcomes are presented in Table 1. All patients underwent
successful surgery with a significant reduction in mean trans-LVOT gradient (9± 6mmHg versus
68± 27mmHg; p < 0.001). There were no hospital mortalities. No patients had a perioperative
myocardial infarction, required pacemaker implantation or required inotropic support after surgery.
Regional LV remodelling
Regional LV thickness
As shown in Table 2, there was a significant decrease in LV thickness (measured at end-diastole) in all
basal segments following surgery, ranging from a 29% decrease in the antero-lateral septum to 41%
decrease in the anterior septum (p < 0.05 for each segment ). Similarly, there was a significant
decrease in regional LV thickness in all segments of the mid-ventricle, ranging from a 16% decrease
in the antero-lateral and infero-septal segments to a 24% decrease in the anterior segment
(p < 0.05 for each segment ). Additionally, a significant reduction in LV wall thickness was observed
in all segments of the apex, except the anterior apical segment (p = 0.23). The decrease in the apical
segments ranged from a 26% decrease in the lateral segment to a 29% decrease in all other
segments (p < 0.05 for each segment ).
Regional LV thickening
There was high variability between patients in the extent of changes in regional LV thickening
following tailored myectomy (Table 3). Nevertheless, there was a noticeable pattern of changes which
consisted of improved thickening in the segments of the base with little change in the other regions
of the ventricle. Thus, there was a significant increase in the LV thickening at the level of the anterior
segment of the base (93% increase; p = 0.02; Table 3). Similarly, there was a trend towards an
increase in LV thickening in all other segments of the base, although this did not reach statistical
significance. The increase ranged from 35% in the infero-septal segment (p = 0.07) to 78% in the
inferior segment of the base (p = 0.08) and 79% in the antero-septal segment (p = 0.09). In
contrast, there was little to no change in the degree of thickening of the various segments of the
mid-ventricle and apex following surgery (Table 3).
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Table 3. Changes in regional LV wall thickening following tailored surgical myectomy for HCM.
LV Segment Preoperative (%) Postoperative (%) % change p-value
Basal
Anterior 38.0± 18.0 73.4± 41.4 +93% 0.02
Antero-Septal 50.4± 37.0 90.0± 63.0 +79% 0.09
Infero-Septal 55.8± 29.5 75.3± 36.6 +35% 0.07
Inferior 58.3± 29.1 103.5± 78.1 +78% 0.08
Infero-Lateral 68.7± 44.7 88.7± 46.3 +29% 0.30
Antero-Lateral 52.5± 31.0 48.4± 32.3 −8% 0.67
Mid
Anterior 49.3± 28.2 58.4± 36.5 +18% 0.51
Antero-Septal 49.7± 31.0 53.8± 29.3 +8% 0.61
Infero-Septal 58.6± 27.8 62.7± 36.6 +7% 0.66
Inferior 69.4± 28.1 73.2± 24.3 +5% 0.71
Infero-Lateral 86.4± 48.4 90.2± 24.8 +4% 0.76
Antero-Lateral 66.4± 25.5 76.0± 33.9 +14% 0.41
Apical
Anterior 75.6± 49.2 76.4± 46.9 +1% 0.96
Septal 70.2± 39.9 67.4± 29.3 −4% 0.83
Inferior 74.3± 30.5 76.0± 33.4 +2% 0.85
Lateral 79.9± 37.2 79.2± 34.0 −1% 0.93
Apex Apex 45.4± 28.6 45.6± 31.0 0% 0.98
Table 4. Changes in global LV function following tailored myectomy for HCM.
Variable Pre-operative Post-operative P-value
Indexed LVEDV (mL/m2) 65.3± 10.8 70± 13.2 0.16
Indexed LVESV (mL/m2) 16± 5.5 22.4± 6.5 < 0.001
Indexed LV stroke volume (mL/m2) 49.4± 10.5 47.8± 9.5 0.6
LV ejection fraction (%) 75± 9 68± 7 < 0.001
Indexed LV mass (g/m2) 154± 36 120± 29 < 0.001
Left Ventricular Remodelling Index1 2.4± 0.7 1.8± 0.6 0.005
LV longitudinal systolic function (MAPSE, mm) 13.3± 3.8 12.1± 4.0 0.2
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LV, left ventricle;MAPSE,mitral annular plane systolic
excursion
1 Measured as the indexed volume/mass ratio
Global LV volume and mass
Changes in global LV volume and mass are described in Table 4. Overall, there was a trend towards a
statistically significant increase in mean indexed LVEDV (70± 13.2mL/m2 post-operatively versus
65.3± 10.8mL/m2 pre-operatively; p = 0.16). There was a parallel statistically significant increase in
mean indexed LVESV (22.4± 6.5mL/m2 post-operatively versus 16± 5.5mL/m2 pre-operatively;
p < 0.001). As a result, there were no changes in mean indexed stroke volume at rest following
surgery (47.8± 9.5mL/m2 post-operatively versus 49.4± 10.5mL/m2 pre-operatively; p = 0.6) and
a significant decrease in mean LVEF from 75± 9% pre-operatively to 68± 7% post-operatively
(p < 0.001). Mean indexed LV mass showed a significant decrease from 154± 36 g/m2 to
120± 29 g/m2 following surgery (p < 0.001). In addition, LV remodelling index was significantly
improved after surgery (1.8± 0.6 post-operatively vs. 2.4± 0.7 pre-operatively; p = 0.005). However,
no significant change in mitral annular plane systolic excursion (longitudinal function) was observed
after surgery (12.1± 4.0mm post-operatively versus 13.3± 3.8mm pre-operatively; p = 0.2).
DISCUSSION
This study illustrates that a tailored surgical approach results in a global and asymmetric pattern of LV
remodelling in all segments of the ventricle, including those remote from the septum. This is
accompanied by an increase in thickening of the basal septal segments following surgery, denoting
improved regional systolic function. The pattern and extent of regional remodelling observed resulted
in overall normalization of LV function and a significant decrease in indexed LV mass which, in
addition to the reduction in LVOT gradient, could have important prognostic significance.
Diffuse LV hypertrophy in patients with HCM is likely due to a combination of two factors: the
disease process affecting all ventricular myocytes and secondary hypertrophy due to increased
afterload. Patients with HCM can present with a variety of patterns of hypertrophy sometimes
involving the entire ventricle [8]. In patients requiring myectomy, it is often difficult to distinguish
between pathogenic mechanisms based on pre-operative cardiac imaging. It is presumed that
secondary hypertrophy is a reversible process whereas the reversibility of primary hypertrophy is less
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likely. The present study shows that relief of obstruction consistently resulted in a significant and
diffuse pattern of regional LV remodelling in an unselected sample of HCM cases.
The exact cause of the regional heterogeneity in the decrease in thickness is not known.
Nevertheless, this could be partially explained by the regional heterogeneity of the changes in
transmural pressures in the different segments following surgery. It is well known that cells in different
parts of the body can sense and adapt to mechanical stimuli such as pressure or flow by translating
them into biological signals such as cell migration, contraction, proliferation and growth factor
synthesis (a process termed mechanotransduction) [21]. Changes in mechanical stimuli can thus
result in changes in the local molecular and signalling environments, leading to varying degrees of
cell size regression or extracellular matrix remodelling. Together, these result in an overall reduction
in wall thickness without loss of contractile function. Another potential explanation for the regional
heterogeneity in the extent of LV remodelling can be explained by differences in developmental
origins of cardiomyocytes within the LV [22–25]. Various studies have demonstrated that cells from
different developmental origins exhibit distinct biological responses to the same mechanical or
biochemical stimuli [26–28]. Therefore, an equal reduction in transmural pressure can be interpreted
differently by cells within the LV, leading to non-uniform remodelling. Apart from understanding the
mechanisms of regression, the overall functional effect of the heterogeneous changes of LV
myocardium on LV shape and pattern of contraction remain undetermined and need to be studied
further. Finally, the heterogeneous pattern of remodelling could be a reflection of the phenotypic
heterogeneity of hypertrophy in patients with HCM [5].
Basal septal systolic function is thought to be an essential component of the function of the LVOT
and contributes to the rapid ejection of a bolus of blood from the flask-shaped LV during systole [5].
Regional analysis of LV thickening in our cohort showed improvement in basal systolic function
following surgery as demonstrated by an increase in thickening in most segments of the base (Fig. 1).
In contrast, although ASA can achieve satisfactory degrees of septal thinning, von Dockum et al.
showed reduced thickening of the septum following ASA using CMR-based analyses [11]. On the
other hand, in our study, there was no change in regional systolic function of the mid-ventricular and
apical segments. This heterogeneous pattern of regional LV thickening following surgery may reflect
the pathophysiological process in obstructive HCM. Because the bulk of the hypertrophy is located in
the septum, surgical myectomy at that site results in improved regional myocardial blood flow and
creates room for ventricular thickening. In contrast, the rest of the ventricle is contracting against an
increased afterload in obstructive HCM, thus requiring maximal thickening to achieve an appropriate
stroke volume. Post-operatively, hemodynamic conditions are significantly different as contractions of
these regions of the LV are not opposed by obstruction at the LVOT. Therefore, a comparable degree
of thickening before and after surgery suggests good preservation of regional LV systolic function in
regions remote from the base.
The sum of the changes in the different LV segments on overall LV shape and function are
characterized by a significant decrease in indexed LV mass, an increase in end-diastolic volumes and
preserved stroke volume at rest. These changes represent a trend towards normalization of these
parameters, particularly LV mass (Table 2). Other groups have shown similar patterns of overall LV
functional changes following surgical myectomy or ASA, using echocardiographic or CMR
imaging [11,29,30]. Van Dockum et al. showed a decrease in septal and non-septal wall mass
following ASA [11]. Similar to our findings, they observed no change in LVEDV, increased LVESV,
decreased LV mass and a normalization of LVEF [11]. Interestingly, following ASA, a statistically
significant (albeit clinically mild) decrease in stroke volume at 1 month after the procedure was
observed [11]. This could potentially be explained by the relatively large size of the infarct caused by
alcohol injection.
The preserved stroke volume in the presence of a significantly lower ventricular mass suggests
improved contractile efficiency following surgery, a result of absence of LVOT obstruction as well as a
presumed improvement in myocardial perfusion in the various regions of the LV. Of course, in view of
the reduction in mitral regurgitation following surgery, a preserved stroke volume results in a net
increase in effective stroke volume index. Similarly, the observed normalization (decrease) in LVEF
(with preserved stroke volume) following surgery, which was also reported in other studies, may
reflect reduction of the hyper-adrenergic drive observed in obstructive HCM patients [1]. This may be
an important factor in explaining the excellent long-term survival and low incidence of ventricular
arrhythmias in myectomy patients.
Page 8 of 9
El-Hamamsy et al. Global Cardiology Science and Practice 2012:9
The clinical significance of our findings is particularly important in light of the known independent
predictors of symptom progression and mortality in patients with HCM. Maron et al. firmly established
the link between obstruction (at rest or provoked) and progression of symptoms and/or survival [7].
Additionally, Spirito et al. suggested a link between maximal LV thickness at echocardiography and
patient survival [10]. Olivotto et al. emphasized the role of indexed LV mass estimated by using 3D
CMR in predicting outcomes [4]. Therefore, by achieving both a significant reduction in LVOT gradient
and a diffuse decrease in regional LV thickness resulting in overall reduced indexed LV mass, a
significant improvement in long-term patient symptoms, quality of life and survival can be expected.
Additionally, de Castro et al. have shown that LVRI varies significantly between different
pathophysiological conditions, with a ratio in healthy individuals close to 1 and a significantly higher
ratio in patients with HCM [31]. The significant decrease in LVRI in this cohort of patients after surgery
strongly supports the positive effects of surgical myectomy on overall diastolic function.
This study has several limitations. The CMR studies were performed at variable time points
following surgery. Although this precludes us from defining the response of the LV at a specific time
point after surgery, HCM is by definition a phenotypically heterogeneous disease. Drawing firm data
on remodelling in a limited number of patients is therefore difficult. Nevertheless, this study
establishes a clear pattern of LV remodelling after a tailored surgical approach. Evaluation of
thickness and thickening at the basal septum using CMR can be challenging. However, the same
method for analysis was used in all studies, therefore ensuring consistency in data analysis.
Evaluation of changes in left atrial volumes by CMR could be of prognostic significance to the
patients. Unfortunately, in the present study, complete imaging at the level of the atria was not
acquired, making such studies incomplete.
CONCLUSION
In conclusion, this study demonstrates that the use of a tailored surgical approach for the treatment
LVOT dysfunction in patients with HCM results in a diffuse and heterogeneous pattern of regional LV
remodelling. This is characterized by a decrease in wall thickness in all segments of the LV along with
an increase in thickening at rest in the basal septal segments. This results in overall reduction in
indexed LV mass and improved contractile efficiency of the ventricle. These findings may have
important clinical and prognostic implications because LVOT obstruction and LV mass are associated
with negative outcomes in patients with HCM. In addition, they have important implications for the
understanding of the pathophysiology of disease, its response to various interventions which could
therefore help further refinement of management.
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